|
Marc LaPointe, Pharm D
Curriculum Vitae
Medical University of South Carolina
Department of Pharmacy Practice
43 Sabin Street, Room QE-213
P.O. Box 250132
Charleston, SC 29425
Tel.: (843) 792-8443
Fax.: (843) 792-3759
Pager: (843) 792-0950 ID# 11963
Education and Training
1995-96 Specialized Residency in Critical Care
Medical University of South Carolina, Charleston.
1993-95 Doctor of Pharmacy
Medical University of South Carolina, Charleston.
1989-93 Bachelor of Science Pharmacy
Université Laval, Québec (Canada).
1991 International Program
University of New-Brunswick, Fredericton (Canada).
1990 International Program
University of Regina, Saskatchewan (Canada).
1987-89 Diploma in Science Studies
Collège de Chicoutimi, Québec (Canada).
Professional Practice Experience
1996- Clinical specialist in Critical Care
Neurosurgery, Surgical-Trauma and Burn intensive care units.
1996- Clinical specialist for spasticity clinic
Medical University of South Carolina
1996-1999 Clinical Coordinator (Intrathecal Pump) - Spasticity
Clinic
Medical University of South Carolina
1995-96 Specialized Residency in Critical Care
Patient Care Unit Pharmacist in Surgical ICU (MUSC, Charleston)
Academic Appointments
1998- Assistant-Professor
MUSC - Department Neurological Surgery.
1998- Assistant-Professor
MUSC - College of Pharmacy.
1997- Coordinator / Specialized Residency Program in Critical
Care
MUSC - College of Pharmacy.
1996-98 Clinical Instructor / Fellow
MUSC - College of Pharmacy.
Committee Appointments
Hospital
1997- Conscious sedation Committee - Chairperson
1997-98 Critical Care Committee
1997-98 Nutrition Committee
Department
1997-99 Policy & Procedure - Pharmacist administering
medication
1997-98 Drug cart standardization
1996-97 Formulary Review Committee
College
1999- Admission Committee
1997- Residency Committee
1999- SNAPhA - Advisor
1997-99 Educational Technology Committee
1997-99 Organization and Administration Self-Study Committee
1997-98 Clinical Therapeutics Committee
Professional Organizations
1998- South Carolina Pharmacy Association
1997- American Society of Health-System Pharmacists
1997- American College of Clinical Pharmacists
1995- South Carolina Board of Pharmacy
1995- Society of Critical Care Medicine
1995- American Heart Association - Basic/Advanced Cardiac
Life Support
1993- Ordre des pharmaciens du Québec
1991-93 Canadian Pharmaceutical Association
Academic experience
1992-93 CAPSI President - Executive Council
Canadian Association of Pharmacy Students and Interns
1992 National Coordinator
Fund raising campaign for LEUCAN and The Candlelighters
Childhood Cancer Foundation of Canada in Faculties of Pharmacy
1991-92 Editor of "CAPSIL" - Executive Council
Member The Canadian Journal of Pharmacy Students and Interns
1991-92 Class President - Third year pharmacy students
Administrative Council Member of the Undergraduate Society
(AGEPUL) École de pharmacie - Université Laval
(Québec)
1990-91 Vice President and Finance Officer Executive Council
Member of the Undergraduate Society (AEPUL) École
de pharmacie - Université Laval (Québec).
Publications
Haase KK, Lapointe M, Haines SJ. Aseptic meningitis after
intraventricular administration of gentamicin. Pharmacotherapy
2001;21:103-107.
Lapointe M, Baillie M, et al. Cyclosporin-induced hemolytic
uremic syndrome and hemorrhagic colitis following renal
transplantation. Clin Transplant 1999;13:526-30.
Haines SJ, Lapointe M. Fibrinolytic agents in the management
of posthemorrhagic hydrocephalus in preterm infants: The
evidence. Accepted for publication in Child's Nervous System
1999;15:226-234.
Lapointe M. Current trend in surgical prophylaxis. J Infect
Dis Pharmacother 1998;3:17-39.
Haines SJ, Lapointe M. Fibrinolytic agents in the treatment
of intraventricular
hemorrhage in adults. Crit Rev Neurosurg 1998;9:169-175.
O'Neil MG, Lapointe M. Administration of amphotericin
B in lipid emulsion. Crit Care Med 1997;25:892-3.
Le groupe des 11. Communiquer: la réponse dans
votre sarrau. Book Sponsored by Whitehall Robins Canada
Inc. regarding communication and patient counselling in
pharmacy (theoretical notions and drug information), 1993.
Posters
Lapointe M, O'Neil M, Cuddy B. A 5-year retrospective and
descriptive evaluation of the value of clinical pharmacists
in a neurosurgery spasticity clinic using an intrathetal
drug delivery device (Medtronic Synchromed Pump). Presented
at the International Congress on Clinical Pharmacy, Orlando,
FL, 1999.
Abstract titled "Does ventricular fibrinolysis prevent
posthemorrhagic hydrocephalus in preterm infants?-A critical
review" presented at the International Society for
Paediatric Neurosurgery, Victoria (Australia), September
1998. Abstract presented by Dr. Haines.
Reeves ST, Circeo LE, O'Neil MG, Lapointe M. Multi-center
efficacy trial of long term continuous infusion dosing of
rocuronium in critical care patient. Poster presented at
the Sixth International Neuromuscular Blocking Meeting.
France, 1997.
White R, Burgess D, Groke C, Friedrich L, Lapointe M.
Differences among intensive care units and comparison to
hospital susceptibility patterns. Poster presented at the
Winter Meeting of American College of Clinical Pharmacists.
San Diego, CA, 1994.
Publications in progress
Harvey S, O'Neil M, Lapointe M. Pharmacologic pain management
in the patient with renal insufficiency. In progress. To
be submitted to Southern Medical Journal, September 2000.
Lapointe M, Page R. Cyclosporin-Azathioprine interaction.
In progress. To be submitted to pharmacotherapy, August
2000.
Lapointe M, Sartoris K, O'Neil M. Vasopressin-induced
cardiac arrhythmia. To be submitted to Annals of Pharmacotherapy,
June 2000.
Presentations
"Update on Stroke". Broadcasted to 15 Health
System Institution in South Carolina. Charleston, September
2000.
"Update in Neurosurgery. Presented at the South Carolina
Critical Care Pharmacy Symposium. Charleston, June 2000.
"Conscious sedation". MUSC Nursing Education
Program sponsored by Roche Laboratories Inc., Charleston,
SC, 2000.
"Sedation in the ICUs: Clinical practice guidelines".
MUSC Nursing Education Program sponsored by Roche Laboratories
Inc., Charleston, SC, 2000.
"The use of an intrathecal baclofen pump to treat
spasticity". Physical Medicine and Rehabilitation Department
Conference. Florence, SC, 1998.
"Surgical prophylaxis". Pharmacia & Upjohn,
Newark, NJ, 1999.
"Pharmacological management of subarachnoid hemorrhage
and vasospasms". Neurosurgery Conference - Nursing
Continuing Education Program. Medical University of South
Carolina, October 1998.
"Surgical Prophylaxis". Infectious Diseases
Pharmacotherapy Symposium
Medical University of South Carolina, September 1998.
"New Drugs-Update". Fifth Annual South Carolina
Emergency Nurses Association Conference.
Charleston, SC, April 1998.
"The use of an intrathecal baclofen pump to treat
spasticity". Physical Medicine and Rehabilitation Department
Conference. Medical University of South Carolina. March
1998.
"ACLS Drugs". In service to Neurology / Neurosurgery
nurses, 1998.
"Conscious Sedation". Inservice the hospital
on the new policy and procedure, 1997.
"Neuromuscular Blockers". In service to MUSC
Surgical ICU Nurses, 1996.
"Review and Updates on antimicrobial agents".
MUSC College of Dentistry, 1996.
"Fosphenytoin: A new antiepileptic". MUSC Critical
Care Nurses Continuing Education
Program, 1996.
"Management of intracranial hypertension". MUSC
Critical Care Nurses Continuing Education Program, 1996.
"The acute management of brain attack: Should we
counterattack with thrombolytics".
Presented at the Medical University of South Carolina, Residency
Seminar, 1996.
"The use of ondansetron in postoperative nausea and
vomiting". Presented at the University of Georgia,
Southeastern Residency Conference, 1996.
"The post-serendipity era in the treatment of epilepsy".
Presented at the Medical University of South Carolina, College
of Pharmacy Grand Rounds, 1995.
"An open-minded approach in the management of nonmalignant
pain syndromes with anticonvulsants". Presented at
the Medical University of South Carolina,
College of Pharmacy Grand Rounds, 1994.
"CAPSI activities and Pharmacy Practice in Canada".
Guest Speaker. Presented at the Annual Meeting of the American
Pharmaceutical Association (APhA) and Academy of Students
in Pharmacy (ASP). Dallas, Texas, 1993.
Teaching Activities
1996-1999 B.S. Pharmacy Clinical Therapeutics
-"Antimicrobial surgical prophylaxis" -"Acid-base
disorders"
-"Stroke"
1996- Pharm.D. Advanced Therapeutics
-"Antimicrobial surgical prophylaxis" -"Acid-base
disorders"
-"Stress ulcer prophylaxis" -"Alcohol liver
disease"
-"The acute management of stroke" -"Status
epilepticus"
-"Nosocomial pneumonia" -"Stroke management"
-"The pharmacokinetic of phenytoin" -"Critically
ill patients-cases"
-"Pharmacokinetic changes in critically ill patients"
1996- Preceptors for B.S. pharmacy students, Pharm.D.
students, specialized and general pharmacy practice residents
in critical care (8 to 10 months per year).
Clinical Projects
Medication Use Evaluation (supervisor): "Surgical prophylaxis
in neurosurgery", 1999-00
Medication Use Evaluation (supervisor): "Surgical
prophylaxis", 1998-99
Medication Use Evaluation (supervisor): "Neuromuscular
blockers", 1997-98.
Medication Use Evaluation (supervisor): "Stress ulcer
prophylaxis", 1996-97.
Pharmacy Consultant on "Phosphenytoin"
Annual Conference of the Society of Critical Care Medicine,
New Orleans, 1996.
Residency Project: "Development of a pain management
protocol in orthopedic patients undergoing total or partial
hip replacement", 1996.
Medication Use Evaluation: "The use of ondansetron
for postoperative nausea and vomiting", 1996-97.
Research Projects
"International multicenter intraventricular hemorrhage
thrombolysis trial". Total budget for
2000-2001: $ 12,000. Co-PI Investigator and Study Coordinator
at MUSC
Development of a novel drug delivery system for treatment
of malignant gliomas. American Cancer Society Institutional
Research Grant Program, $ 16,964. Principal Investigator.
October 2000.
"Propofol for sedation in neurosurgery". Educational
grant from Astra Zeneca, $ 1,500. Principal investigator.
September 2000.
"International multicenter intraventricular hemorrhage
thrombolysis trial". Total budget for 1999-2000: $
12,000. Co-PI Investigator and Study Coordinator at MUSC.
"Phase I / II open-label, non-randomized, multicenter,
dose-escalating study of interstitial 131 I- chTNT-1/B for
the treatment of recurrent supratentorial anaplastic astrocytoma
and glioma multiforme". Budget: approx. $ 750,000.
Sub-investigator.
Educational Grant. $ 5,000. Hoffman- La Roche Pharmaceutical.
Evaluation of sedation in critically ill neurosurgery patients,
October 1998.
Educational Grant. $ 2,000. Hoffman - La Roche Pharmaceutical.
Guidelines for conscious sedation. November 1998.
Trovafloxacin pharmacokinetics in patients with thermal
injury. Co-Principal investigator.
"Multicenter randomized open label study evaluating
the cost effectiveness of amphotericin B colloidal dispersion
and amphotericin B in Fungal infections.
Indirect Total Grant $ 10,000. Co-investigator at MUSC for
surgical ICUs.
"Interaction of Nimodipine with enteral nutrition
in critically ill patients". Educational Grant $ 3,000
from Bayer Pharmaceutical Division.
"Multicenter safety and efficacy trial of long term
infusion dosing of Rocuronium Bromide in critical care patients.
Research Grant $ 7,000 for participation. Total budget $
20,000.
"Comparison of the relationship between susceptibility
pattern and drug usage in intensive care units versus the
hospital as a whole", 1993-95.
Preceptor: Dr. Roger White (Medical university of South
Carolina)
Miscellaneous Research Projects
Patel S, Lapointe M. Use of hydroxyurea for the treatment
of recurrent meningioma.
Ongoing open-label study.
Honors and Recognition
2002 Most distinguished pharmacist in South Carolina
2000 Preceptor of the Year
South Carolina Chapter - American Society of Health System
Pharmacists
1996 Division of information Development Awards
United States Pharmacopeia
1995 Honor Mention for College of Pharmacy Grand Rounds
Medical University of South Carolina
1994 Honor Mention for College of Pharmacy Grand Rounds
Medical University of South Carolina
1993 Support Grants for Advanced Training in Clinical Practice
Canadian Foundation for Pharmacy. Awarded to three Canadian
students who pursue clinical training and demonstrate academic
performance and professional interest.
1993 "J. Antonin Marquis" Award
Ordre des Pharmaciens du Québec. Awarded to a graduate
who has demonstrated leadership through academic and professional
activities.
1992-93 Past-President Award
Bristol-Myers Squibb. Awarded for contribution to the profession
of pharmacy in Canada.
1992-93 Nomination for "Student of the year"
1991 National Compounding Competition School representative,
Université Laval (Canada).
1991-92 Nomination for the "Centenial Scholar"
Award
1990-91 Eli Lilly Award
School of Pharmacy, Université Laval. Awarded to
the second year student who obtained high academic marks
and showed great interest in university activities.
|
